NO20090993L - BIQ-markorer for vurdering av leverfunksjon - Google Patents

BIQ-markorer for vurdering av leverfunksjon

Info

Publication number
NO20090993L
NO20090993L NO20090993A NO20090993A NO20090993L NO 20090993 L NO20090993 L NO 20090993L NO 20090993 A NO20090993 A NO 20090993A NO 20090993 A NO20090993 A NO 20090993A NO 20090993 L NO20090993 L NO 20090993L
Authority
NO
Norway
Prior art keywords
liver function
biq
markers
assessment
individual
Prior art date
Application number
NO20090993A
Other languages
English (en)
Inventor
Rajiv Jalan
Rajeshwar P Mookerjee
Nathan Davies
Original Assignee
Ucl Business Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucl Business Plc filed Critical Ucl Business Plc
Publication of NO20090993L publication Critical patent/NO20090993L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
    • G01N2333/765—Serum albumin, e.g. HSA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/08—Hepato-biliairy disorders other than hepatitis
    • G01N2800/085—Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

En fremgangsmåte for å vurdere leverfunksjon i et individ, hvilken fremgangsmåte omfatter å bestemme nivået av metylarginin(er) (slike som ADMA og/eller SDMA) og forholdet av iskemimodifisert albumin (IMA): albuminforhold (IMAR) i individet, for derved å vurdere leverfunksjon i individet.
NO20090993A 2006-09-07 2009-03-05 BIQ-markorer for vurdering av leverfunksjon NO20090993L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0617581.4A GB0617581D0 (en) 2006-09-07 2006-09-07 Biomarkers for assessing liver function
PCT/GB2007/003362 WO2008029145A1 (en) 2006-09-07 2007-09-07 Biqmarkers for assessing liver function

Publications (1)

Publication Number Publication Date
NO20090993L true NO20090993L (no) 2009-04-03

Family

ID=37232490

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090993A NO20090993L (no) 2006-09-07 2009-03-05 BIQ-markorer for vurdering av leverfunksjon

Country Status (16)

Country Link
US (1) US8455220B2 (no)
EP (1) EP2059817B1 (no)
JP (1) JP4949473B2 (no)
KR (1) KR20090083335A (no)
AT (1) ATE488772T1 (no)
AU (1) AU2007293302A1 (no)
CA (1) CA2662597A1 (no)
DE (1) DE602007010644D1 (no)
EA (1) EA200970256A1 (no)
ES (1) ES2353835T3 (no)
GB (1) GB0617581D0 (no)
IL (1) IL197271A0 (no)
MX (1) MX2009002378A (no)
NO (1) NO20090993L (no)
WO (1) WO2008029145A1 (no)
ZA (1) ZA200901432B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012262329B2 (en) 2011-05-31 2014-10-16 The Regents Of The University Of Colorado, A Body Corporate Method for assessment of hepatic function and portal blood flow
CN105452857B (zh) 2012-11-12 2019-06-28 科罗拉多州立大学董事会法人团体 评价慢性肝病的疾病严重性指标
US10054600B2 (en) 2013-05-22 2018-08-21 The Regents Of The University Of California Biomarker composite test for hepatic vein pressure gradient and cirrhosis treatment
PL3209317T3 (pl) 2014-10-24 2022-05-23 Mallinckrodt Pharmaceuticals Ireland Limited Terlipresyna do leczenia zespołu wątrobowo-nerkowego typu 1
CN105181692A (zh) * 2015-09-30 2015-12-23 山东博科生物产业有限公司 一种缺血修饰白蛋白比色法检测试剂盒
ES2761266T3 (es) 2015-11-10 2020-05-19 Inst Nat Sante Rech Med Métodos para predicción del tiempo de supervivencia de los pacientes con cirrosis alcohólica descompensada

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997034605A1 (en) * 1996-03-21 1997-09-25 Mayo Foundation For Medical Education And Research Use of nicotine to treat liver disease
EP1299398A1 (en) * 2000-07-06 2003-04-09 Fal Diagnostics Methods and kits for the detection of arginine compounds
US7063782B2 (en) * 2001-11-26 2006-06-20 Ischemia Technologies, Inc. Electrochemical detection of ischemia
WO2004012686A2 (en) 2002-08-06 2004-02-12 Nitromed, Inc. Nitrosated and/or nitrosylated ursodeoxycholic acid compounds, compositions and methods of use
WO2004046314A2 (en) 2002-11-15 2004-06-03 The Board Of Trustees Of The Leland Stanford Junior University Methods for detecting asymmetric dimethylarginine in a biological sample
WO2005039598A1 (en) * 2003-10-24 2005-05-06 Intermune, Inc. Method of treating alcoholic liver disease
DE10351238A1 (de) * 2003-11-03 2005-06-02 Roche Diagnostics Gmbh Diagnosestellung von akuten myokardialen, ischämischen Erkrankungen durch Kombination von Markern

Also Published As

Publication number Publication date
ATE488772T1 (de) 2010-12-15
CA2662597A1 (en) 2008-03-13
EP2059817B1 (en) 2010-11-17
JP4949473B2 (ja) 2012-06-06
ZA200901432B (en) 2010-06-30
ES2353835T3 (es) 2011-03-07
KR20090083335A (ko) 2009-08-03
EA200970256A1 (ru) 2009-08-28
IL197271A0 (en) 2009-12-24
EP2059817A1 (en) 2009-05-20
US20090280519A1 (en) 2009-11-12
GB0617581D0 (en) 2006-10-18
JP2010502979A (ja) 2010-01-28
MX2009002378A (es) 2009-03-20
AU2007293302A1 (en) 2008-03-13
DE602007010644D1 (de) 2010-12-30
WO2008029145A1 (en) 2008-03-13
US8455220B2 (en) 2013-06-04

Similar Documents

Publication Publication Date Title
NO20090993L (no) BIQ-markorer for vurdering av leverfunksjon
BRPI0811549A2 (pt) Inibidor de carepa à base de polissacarídeos.
DE102006039633A8 (de) Chromfreies, thermisch härtbares Korrosionsschutzmittel
GB0617429D0 (en) Markers of renal transplant rejection and renal damage
ATE446090T1 (de) Thiadiazolidinone als gsk3-inhibitoren
WO2009125401A3 (en) Compositions and methods for enhancing oil content in plants
DE602006020301D1 (de) Schnellverbinder
WO2006089091A3 (en) Methods for detecting minimum residual disease
WO2008019160A3 (en) Method for identifying refractive-index fluctuations of a target
WO2009037473A3 (en) Nucleobase characterisation
ATE433124T1 (de) System und verfahren zum analysieren von radarinformationen
ATE493485T1 (de) Hochtemperaturkorrosionsinhibitor
WO2007081788A3 (en) Calpastatin markers for fertility and longevity
WO2008036306A3 (en) Systems and methods for receiving pathogen related information and responding
WO2006105170A3 (en) Systems and methods for determining cost of capital for an entity in a bottom-up, fully risk-based manner
ITTO20040849A1 (it) Tubazione per carburante.
ITTO20060036A1 (it) Circuito idraulico.
WO2008043543A3 (en) Nucleic acid beacons for fluorescent in-situ hybridisation and chip technology
WO2008034622A3 (en) A method of detecting and/or quantifying expression of a target protein candidate in a cell, and a method of identifying a target protein of a small molecule modulator
WO2007002574A3 (en) Cspcna isoform modifications and uses thereof
ATE461189T1 (de) Neue 6-pyridylphenanthridine
FR2925494B1 (fr) Nouvelles aminoindolizines, composition tinctoriale comprenant une aminoindolizine, procedes et ustilisations.
FI20050681A (fi) Paikoitusmenetelmä
DE502006003125D1 (de) Vorrichtung zur druckbasierten lasterfassung
DE602007010939D1 (de) Abcbi-genotypisierung zur vorhersage der mikrotubuli-stabilisatorwirkstoffinduzierten toxizität

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application